{
 "PrintNo":"A3927","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-01-29T15:41:46.52791Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-29","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":622,"Name":"Thomas Abinanti","Short":"ABINANTI"}],"Title":"Relates to epinephrine injector device",
 "Summary":"Relates to epinephrine injector devices.","LawSection":"Public Health Law",
 "LawCode":"Amd ยง3000-c, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to epinephrine injector devices",
 "SameAsPrintNo":"S2537-2021","PreviousVersions":["A9964-2019"]
}